These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38741591)

  • 1. The impacts of natural product miltirone and the CYP2D6 pharmacogenetic phenotype on fluoxetine metabolism.
    Zhang X; Li Q; Ye X; Chen Q; Chen C; Hu G; Zhang L; Chen L
    Front Pharmacol; 2024; 15():1373048. PubMed ID: 38741591
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 22 CYP2D6 Genetic Variations Newly Identified in Chinese Population on Olanzapine Metabolism in vitro.
    Zhou HY; Gu EM; Chen QL; Zhan YY; Wang SH; Liang BQ; Dai DP; Cai JP; Hu GX
    Pharmacology; 2016; 98(3-4):124-33. PubMed ID: 27251229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of wild-type and 24 CYP2D6 allelic variants on gefitinib metabolism in vitro.
    Fang P; Zheng X; He J; Ge H; Tang P; Cai J; Hu G
    Drug Des Devel Ther; 2017; 11():1283-1290. PubMed ID: 28461741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 22 novel CYP2D6 variants found in Chinese population on the metabolism of dapoxetine.
    Xu RA; Gu EM; Zhou Q; Yuan L; Hu X; Cai J; Hu G
    Drug Des Devel Ther; 2016; 10():687-96. PubMed ID: 26937172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 24 CYP2D6 Variants on the Metabolism of Nebivolol In Vitro.
    Hu X; Lan T; Dai D; Xu RA; Yuan L; Zhou Q; Li Y; Cai J; Hu G
    Drug Metab Dispos; 2016 Nov; 44(11):1828-1831. PubMed ID: 27538917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 24 CYP2D6 Variants Found in the Chinese Population on the Metabolism of Risperidone.
    Wang ZH; Zhan YY; Li YX; Yang CC; Cai J; Dai DP; Hu GX; Cai JP
    Pharmacology; 2015; 96(5-6):290-5. PubMed ID: 26544071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 22 CYP2D6 variants found in the Chinese population on tolterodine metabolism in vitro.
    Wang H; Dai DP; Sun P; Xu LP; Liang BQ; Cai JP; Hu GX
    Chem Biol Interact; 2017 Feb; 264():10-15. PubMed ID: 28087463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro assessment of 24 CYP2D6 allelic isoforms on the metabolism of methadone.
    Su Y; Zhan YY; Wang BF; Wang SC; Dai DP; Hu GX; Lin H; Lian QQ; Cai JP
    Drug Test Anal; 2017 Feb; 9(2):216-220. PubMed ID: 26968424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the Mechanism of Fluoxetine-Mediated CYP2D6 Inhibition.
    Deodhar M; Rihani SBA; Darakjian L; Turgeon J; Michaud V
    Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33498694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing the effect of cytochrome P450 (CYP) 2C8, CYP2C9, and CYP2D6 genetic polymorphisms on stereoselective N-demethylation of fluoxetine.
    Wang Z; Wang S; Huang M; Hu H; Yu L; Zeng S
    Chirality; 2014 Mar; 26(3):166-73. PubMed ID: 24464553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2D6 gene polymorphism and apatinib affect the metabolic profile of fluvoxamine.
    Ye Z; Chen B; Gao N; Kong Q; Hu X; Lu Z; Qian J; Hu G; Cai J; Wu B
    Front Pharmacol; 2022; 13():985159. PubMed ID: 36120346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine.
    Scordo MG; Spina E; Dahl ML; Gatti G; Perucca E
    Basic Clin Pharmacol Toxicol; 2005 Nov; 97(5):296-301. PubMed ID: 16236141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 24 CYP2D6 variants found in Chinese population on the metabolism of clonidine in vitro.
    Li XY; Hu XX; Yang F; Yuan LJ; Cai JP; Hu GX
    Chem Biol Interact; 2019 Nov; 313():108840. PubMed ID: 31585114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CYP2D6 and CYP2C9 genotypes on fluoxetine and norfluoxetine plasma concentrations during steady-state conditions.
    LLerena A; Dorado P; Berecz R; González AP; Peñas-LLedó EM
    Eur J Clin Pharmacol; 2004 Feb; 59(12):869-73. PubMed ID: 14726986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine.
    Ring BJ; Eckstein JA; Gillespie JS; Binkley SN; VandenBranden M; Wrighton SA
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1044-50. PubMed ID: 11356927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine impairs the CYP2D6-mediated metabolism of propafenone enantiomers in healthy Chinese volunteers.
    Cai WM; Chen B; Zhou Y; Zhang YD
    Clin Pharmacol Ther; 1999 Nov; 66(5):516-21. PubMed ID: 10579479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of fluoxetine and duloxetine on the pharmacokinetics of metoprolol in vivo and in vitro.
    Xu T; Gao N; Li Y; Wang R; Chen B; Hu G; Zhang X
    Fundam Clin Pharmacol; 2022 Dec; 36(6):1057-1065. PubMed ID: 35510497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17.
    Shen H; He MM; Liu H; Wrighton SA; Wang L; Guo B; Li C
    Drug Metab Dispos; 2007 Aug; 35(8):1292-300. PubMed ID: 17470523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro assessment of 39 CYP2C9 variants found in the Chinese population on the metabolism of the model substrate fluoxetine and a summary of their effects on other substrates.
    Ji Y; Chen S; Zhao L; Pan P; Wang L; Cai J; Dai D; Hu G; Cai JP; Huang H
    J Clin Pharm Ther; 2015 Jun; 40(3):320-7. PubMed ID: 25884291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of 22 novel CYP2D6 variants for the metabolism of Tamoxifen.
    Hu XX; Zhou Q; Lan T; Huang XX; Liang BQ; Dai DP; Cai JP; Hu GX
    J Pharm Pharmacol; 2016 Jun; 68(6):819-25. PubMed ID: 27109434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.